HDMA’s Gallenagh receives Distribution Management Award for Industry Leadership
ARLINGTON, Va. — The Healthcare Distribution Management Association, the national association representing primary healthcare distributors, has honored Elizabeth Gallenagh, SVP government affairs and general counsel, with the Distribution Management Award for Industry Leadership.
The award, presented at the HDMA 2014 Distribution Management Conference and Technology Expo in Palm Desert, Calif., honors an individual who has exhibited the highest standards of honesty and integrity, working to enhance industry relations and knowledge, as well as supply chain efficiency and security. Award winners are selected by the Association’s Industry Relations Council, made up of HDMA-member distributor and manufacturer executives.
Since joining HDMA in 2003, Gallenagh led the Association’s industry-wide efforts to replace a 50-state patchwork of pedigree laws with one national traceability solution, which became a reality through the enactment of Title II of the Drug Quality and Security Act in November 2013. Through Gallenagh’s work and expertise, HDMA and its distributor members were able to shape the discussion around the policies and regulations that defined the legislation, while building consensus with fellow stakeholders. Gallenagh is now leading HDMA’s efforts surrounding implementation.
“The enactment of the DQSA was one of the most significant legislative achievements ever accomplished by our industry. It could not have happened without Liz’s knowledge and tenacity. We appreciate her efforts and are pleased to honor her with this award,” said HDMA president and CEO John Gray.
Hannaford: Sign up for Healthy Saver Plus, get discount on produce
SCARBOROUGH, Maine — Hannaford Supermarkets is promoting its Healthy Saver Plus Program — which provides patients with cost savings on prescriptions, diabetic supplies and more — by offering $10 off on produce for new members.
According to the grocer’s website, the offer lasts through the end of March at any Hannaford pharmacy.
The program costs $7 a year and members receive such benefits as savings on prescription medications, savings on immunizations and savings on select diabetic testing supplies and children’s fluoride tablets at no cost.
Study finds vitamin D boosts breast cancer survival
SAN DIEGO — According to recently released research, breast cancer patients were twice as likely to survive the disease if they had high levels of vitamin D in their blood.
University of California, San Diego School of Medicine researchers reported the findings in the March issue of Anticancer Research.
“Vitamin D metabolites increase communication between cells by switching on a protein that blocks aggressive cell division,” said Cedric F. Garland, professor in the department of family and preventive medicine. “As long as vitamin D receptors are present, tumor growth is prevented and kept from expanding its blood supply. Vitamin D receptors are not lost until a tumor is very advanced. This is the reason for better survival in patients whose vitamin D blood levels are high.”
In prior studies, Garland showed that low vitamin D levels were linked to a high risk of premenopausal breast cancer. That finding, he said, prompted him to question the relationship between 25-hydroxyvitamin D — a metabolite produced by the body from the ingestion of vitamin D — and breast cancer survival rates.
Garland and colleagues then performed a statistical analysis of five studies of 25-hydroxyvitamin D obtained at the time of patient diagnosis and their follow-up for an average of nine years. Combined, the studies included 4,443 breast cancer patients.
Women in the high serum group had an average level of 30 nanograms per milliliter (ng/ml) of 25-hydroxyvitamin D in their blood. The low group averaged 17 ng/ml. The average level in patients with breast cancer in the United States is 17 ng/ml, researchers said.